FORM 8-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 CURRENT REPORT Pursuant to Section 13 or 15(d) of the Date of Report (Date of earliest event reported): March 6, 2003 MEDTOX SCIENTIFIC, INC. Delaware 1-11394 95-3863205 (651) 636-7466 |
Item 9. Regulation FD Disclosure On March 6, 2003, the Company held its quarterly conference call and announced revenues and earnings for the fourth quarter and year-end December 31, 2002, as described in the conference call script attached as Exhibit 99.1. |
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. |
MEDTOX Scientific, Inc.
Date: March 6, 2003 By: /s/ Richard J. Braun
Name: Richard J. Braun
Title: Chief Executive Officer